Hair it is: The long and short of monitoring antiretroviral treatment

Annals of Internal Medicine

Volumn 137, Issue 8, 2002, Pages 696-697

  Gandhi, Monica ^a   Greenblatt, Ruth M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG EFFICACY; DRUG MONITORING; HAIR ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE;

EID: 0037108644     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-8-200210150-00016     Document Type: Review

References (20)

1. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279:1977-83. [PMID: 9643862]
2. Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquit Immune Defic Syndr. 2001;26:82-92. [PMID: 11176272]
3. Moyer TP, Temesgen Z, Enger R, Estes L, Charlson J, Oliver L, et al. Drug monitoring of antiretroviral therapy for HIV-1 infection: method validation and results of a pilot study. Clin Chem. 1999;45:1465-76. [PMID: 10471649]
4. Farmer IC Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074-90. [PMID: 10440628]
5. Duong M, Piroth L, Peytavin G, Forte F, Kohli E, Grappin M, et al. Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response. Clin Infect Dis. 2001;33:386-92. [PMID: 11438909]
6. Bernard L, Vuagnat A, Peytavin G, Hallouin MC, Bouhour D, Nguyen TH, et al. Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy. Ann Intern Med. 2002;137:656-9.
7. Bernard L, Peytavin G, Vuagnat A, de Truchis P, Perronne C. Indinavir concentrations in hair from patients receiving highly active antiretroviral therapy [Letter]. Lancet. 1998;352:1757-8. [PMID: 9848361]
8. Servais J, Peytavin G, Arendt V, Staub T, Schneider F, Hemmer R, et al. Indinavir hair concentration in highly active antiretroviral therapy-treated patients: association with viral load and drug resistance [Letter]. AIDS. 2001;15: 941-3. [PMID: 11399971]
9. Nakahara Y. Hair analysis for abused and therapeutic drugs. J Chromatogr B Biomed Sci Appl. 1999;733:161-80. [PMID: 10572981]
10. Tsatsakis AM, Psillakis T, Paritsis N. Phenytoin concentration in head hair sections: a method to evaluate the history of drug use. J Clin Psychopharmacol. 2000;20:560-73. [PMID: 11001242]
11. Cirimele V, Kintz P, Gosselin O, Ludes B. Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients. Forensic Sci Int. 2000;107:289-300. [PMID: 10689581]
12. Wilkins DG, Valdez AS, Nagasawa PR, Gygi SP, Rollins DE. Incorporation of drugs for the treatment of substance abuse into pigmented and nonpigmented hair. J Pharm Sci. 1998;87:435-40. [PMID: 9548895]
13. Kronstrand R, Förstberg-Peterson S, Kågedal B, Ahlner J, Larson G. Codeine concentration in hair after oral administration is dependent on melanin content. Clin Chem. 1999;45:1485-94. [PMID: 10471651]
14. Pötsch L, Skopp G, Becker J. Ultrastructural alterations and environmental exposure influence the opiate concentrations in hair of drug addicts. Int J Legal Med. 1995;107:301-5. [PMID: 7577693]
15. Jurado C, Kintz P, Menéndez M, Repetto M. Influence of the cosmetic treatment of hair on drug testing. Int J Legal Med. 1997;110: 159-63. [PMID: 9228567]
16. Röhrich J, Zörntlein S, Pötsch L, Skopp G, Becker J. Effect of the shampoo Ultra Clean on drug concentrations in human hair. Int J Legal Med. 2000;113: 102-6. [PMID: 10741485]
17. Kosuge K, Uematsu T, Araki SI, Matsuno H, Ohashi K, Nakashima M. Comparative dispositions of ofloxacin in human head, axillary, and pubic hairs. Antimicrob Agents Chemother. 1998;42:1298-302. [PMID: 9593174]
18. Cassani M, Da Re N, Giuliani L, Sesana F. Experience with hair testing in the clinical biochemistry laboratory of Ca' Granda Niguarda Hospital, Milan, Italy. Forensic Sci Int. 1997;84:17-24. [PMID: 9042706]
19. Skopp G, Pötsch L, Mauden M. Stability of cannabinoids in hair samples exposed to sunlight. Clin Chem. 2000;46:1846-8. [PMID: 11067826]
20. Wainhaus SB, Tzanani N, Dagan S, Miller ML, Amirav A. Fast analysis of drugs in a single hair. J Am Soc Mass Spectrom. 1998;9:1311-20. [PMID: 9835076]